Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Drug Use Investigation for LAMICTAL

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01376180
First received: June 16, 2011
Last updated: November 8, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2016
  Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)